Program Overview
Presentations will be delivered virtually.
NOTE: Agenda subject to change
Day 1
Day 2
Day 1
Agenda – Friday, April 30
Times for each day are in CST
| Date/Time Friday, April 30 | Allied Healthcare Professionals Session | Presenter |
| 8:00 AM – 8:15 AM | WELCOME AND INTRODUCTIONS | Sonali Smith, MD, FASCO |
| 8:15 AM – 9:15 AM | Quality of Life Assessment and Symptom Management for AYA Patients Download Slides | Adam DuVall, MD, MPH |
| 9:15 AM – 10:15 AM | Targeted Agents in B-cell Malignancies (New Drugs, Mechanism of Action, Toxicity) Download Slides | Jennifer Santamala, PharmD, BCOP View Presentations |
| 10:15 AM – 10:30 AM | Q&A | |
| 10:30 AM – 11:00 AM | BREAK & VIRTUAL EXHIBITS | |
| 11:00 AM – 11:45 AM | Primer on Immunology Download Slides | Justin Kline, MD |
| 11:45 AM– 12:30 PM | Manage irAEs with Novel Immunotherapies Download Slides | Corinne Williams, PA-C View Presentations |
| 12:30 PM– 12:45 PM | Q&A | |
| 12:45 AM– 12:55 PM | Session Wrap-Up and Closing | Sonali Smith, MD, FASCO |
| Date/Time Friday, April 30 | General Session | Presenter |
| 1:00 PM – 1:10 PM | WELCOME AND INTRODUCTIONS | IUCLS Chairs |
Mini Symposium on Agressive Lymphomas | ||
| 1:10 PM – 1:15 PM | Pre-session ARS | |
| 1:15 PM – 1:35 PM | Treatment Approaches for Elderly Patients with DLBCL | Stefano Luminari, MD |
| 1:35 PM – 1:55 PM | Debate: CAR T-cell Therapy vs Chemotherapy + Autologous Transplant | Mehdi Hamadani, MD & Frederick Locke, MD |
| 1:55 PM – 2:15 PM | Current Treatment Options for Relapsed/Refractory CTCL | Lauren Pinter-Brown, MD |
| 2:15 PM – 2:45 PM | R/R MCL: The Emerging Landscape of Options | Nirav Shah, MD |
| 2:45 PM – 3:00 PM | Post-Session ARS, Panel Discussion and Q&A View Presentations on Aggressive Lymphomas | |
| 3:00 PM – 3:15 PM | BREAK & VIRTUAL EXHIBITS | |
| 3:15 PM – 4:15 PM | Hematopathology Tumor Board Discussion Download Slides Case 1 Download Slides Case 3 | Girish Venkataraman, MD; Amir Behdad, MD; Valentina Nardi, MD; Jayalakshmi Balakrishna, MD |
| 4:15 PM – 4:30 PM | Post-session ARS, Panel Discussion and Q&A View Hematopathology Presentations | |
| 4:30 PM – 5:00 PM | General Session Wrap Up and Summary | IUCLS Chairs |
| 5:00 PM | Adjourn | |
Day 2
Agenda – Saturday, May 1
Times for each day are in CST
| Date/Time Saturday, May 1 | General Session / Agenda Topic | Presenter |
| 8:00 AM – 8:10 AM | WELCOME AND INTRODUCTIONS | IUCLS Chairs |
Mini Symposium on Indolent Lymphomas | ||
| 8:10 AM – 8:15 AM | Pre-session ARS | |
| 8:15 AM – 8:45 AM | Marginal Zone Lymphoma Download Slides | M. Lia Palomba, MD |
| 8:45 AM – 9:15 AM | Beyond BTK and BCL2: What’s Next for CLL? Download Slides | MD Jennifer Woyach, MD |
| 9:15 AM – 9:45 AM | Therapeutic Strategies in Newly Diagnosed Waldenstroms Macroglobulinemia | Meletios Dimopoulos, MD |
| 9:45 AM – 10:00 AM | Post-session ARS, Panel Discussion and Q&A View Presentations on Indolent Lymphomas | |
| 10:00 AM – 10:15 AM | BREAK & VIRTUAL EXHIBITS | |
Primary and Secondary CNS Lymphoma | ||
| 10:15 AM – 10:20 AM | Pre-session ARS | |
| 10:20 AM – 10:50 AM | Primary CNS Lymphoma Download Slides | Lakshmi Nayak, MD |
| 10:50 AM – 11:20 AM | CNS Lymphoma Prophylaxis | Andres Ferreri, MD |
| 11:20 AM – 11:35 AM | Post-session ARS, Panel Discussion and Q&A | |
Mini Symposium on Targeted and Cellular Therapies | ||
| 11:35 AM – 11:40 AM | Pre-session ARS | |
| 11:40 AM – 12:00 PM | Predicting Efficacy and Toxicity with CAR T-cells | Michael Green, PhD |
| 12:00 PM – 12:20 PM | Bispecific Antibodies and How to Integrate Practice Download Slides | Rajat Bannerji, MD, PhD |
| 12:20 PM – 12:40 PM | Antibody-Drug Conjugates | Laurie Sehn, MD, MPH |
| 12:40 PM – 1:00 PM | Post-session ARS, Panel Discussion and Q&A View Presentations on CNS Lymphoma and Cellular Therapies | |
| 1:00 PM – 1:30 PM | LUNCH & VIRTUAL EXHIBITS | |
Mini Symposium on Imaging | ||
| 1:30 PM – 1:35 PM | Pre-session ARS | |
| 1:35 PM – 1:55 PM | Imaging in Lymphoma: From Gallium to Radiomics – What We Know Now | Judith Trotman, MBChB, FRACP, FRCPA |
| 1:55 PM – 2:15 PM | Interim Scans in Aggressive Lymphomas | Lale Kostakoglu, MD, MPH |
| 2:15 PM – 2:35 PM | New Imaging Techniques | Heiko Schoder, MD, MBA |
| 2:35 PM – 2:45 PM | Post-session ARS, Panel Discussion and Q&A | |
| 2:45 PM – 3:05 PM | Impact of COVID-19 on Lymphoma Treatment Q&A Download Slides | Elizabeth Brem, MD |
| 3:05 PM – 3:15 PM | Q&A | |
| 3:15 PM – 4:15 PM | Keynote: Next Steps in Follicular Lymphoma | Gilles Salles, MD |
| 4:15 PM – 4:30 PM | Q&A | |
| 4:30 PM – 4:50 PM | What Is the Best Second Line Treatment for Hodgkin Lymphoma? | Alison Moskowitz, MD |
| 4:50 PM – 5:00 PM | Q&A | |
| 5:00 PM – 5:15 PM | Summary and Best of IUCLS | IUCLS Chairs |
| 5:15 PM | Adjourn View Presentations on Imaging, COVID-19, FL and HL | |
